PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Endocrinology, Diabetes, and Metabolism, Massachusetts General Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America. Electronic address: scromer@mgh.harvard.edu.\', \'Division of Endocrinology, Diabetes, and Metabolism, Massachusetts General Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America.\', \'Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton, FL, United States of America.\', \'Division of Endocrinology, Diabetes, and Metabolism, Massachusetts General Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America; Division of Endocrinology, Boston Children\'s Hospital, Boston, MA, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1056-8727(22)00025-310.1016/j.jdiacomp.2022.108145
?:hasPublicationType
?:journal
  • Journal of diabetes and its complications
is ?:pmid of
?:pmid
?:pmid
  • 35148936
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.317
?:rankingScore_hIndex
  • 74
is ?:relation_isRelatedTo_publication of
?:title
  • Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: Associated factors, short-term outcomes, and long-term glycemic phenotypes.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all